Foreword
Glocalisation in Pharma
Facilitating the industry growth
The pandemic made medicine accessibility challenging worldwide
Executives Special Issue
Pharma perspectives and insights
Our Executive Special issues are designed to focus on a theme or a sector trend This allows the magazines advisory board and author community to share their perspectives and insights on key issues impacting and influencing the pharma industry
Future of Pharmacovigilance
Emerging role of AI
Healthcare data plays a key role in improving quality of life as accurate data can help doctors patients and other stakeholders involved take the right decisions
Indian Pharma
Innovation paves the way for growth
The Indian pharma industry has played a crucial role in supporting the global battle against the COVID pandemic by supplying essential drugs and vaccines
Biosimilars and Biologics
Opportunities for blockbuster growth
The COVID pandemic has impacted many industries alike and the impact on biosimilars market was no different Lockdowns causing short fall of resources delays in clinical trials slowdown in FDA approvals of nonCOVID drugs have influenced the RD activities and the biosimilars pipeline
Life Sciences and The Ecosystem Paradigm
In April this year three companiesUS real estate investment company Harrison Street UK real estate group Trinity Investment Management and Nottinghambased science business incubator BioCitymerged to create Britains largest life sciences ecosystem to strengthen RD and drug discovery in the country
Precision Medicine
Personalising health outcomes
In recent years precision medicine has emerged as a promising tool for providing patients suffering from complex diseases with comprehensive care Whether it is traumatic cancer cardiac disease lung disorder or COVID for that matter the precision medicine approach has proved to be very effective in improving patients health or reduction of disease s...
Virtual Clinical Trials
The new normal?
Across the world one thing that has been a hot topic since the pandemic started is the arrival of a COVID vaccine COVID led several pharma companies to pursue vaccine production with aggressive deadlines and a sense of urgency in developing and bringing to market
Pharma in the Post-COVID Era
Going digital
We live in the digital era but one would have never imagined a world with little or significantly lesser inperson interaction COVID has consumed numerous lives crippled economies and left millions in distress
Patient Enrolment
Doing it the physical+digital way
Clinical trials are imperative for testing drugs and therapies advancing the science of care and coming up with an effective treatment approach to enhance outcomes for patients
